Synopsis
Synopsis
0
VMF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Decadron Phosphate
2. Dexamethasone 21-phosphate
3. Dexamethasone 21-phosphate, (6alpha,11beta,16alpha)-isomer
4. Dexamethasone 21-phosphate, Copper (+2) Salt (2:3), (11beta,16alpha)-isomer
5. Dexamethasone 21-phosphate, Disodium Salt, (11beta,16alpha)-isomer
6. Dexamethasone 21-phosphate, Disodium Salt, (6alpha,11beta,16alpha)-isomer
7. Dexamethasone 21-phosphate, Monosodium Salt, (11beta,16alpha)-isomer
8. Dexamethasone 21-phosphate, Sodium Salt, (11beta,16alpha)-isomer
9. Dexamethasone Phosphate
10. Dexamethasone Phosphate Disodium Salt
11. Dexamethasonedisodium Phosphate
12. Solu- Decadron
13. Spersadex
14. Spersadox
1. 2392-39-4
2. Dexamethasone 21-phosphate Disodium Salt
3. Dalalone
4. Dexadreson
5. Dexamethasone Disodium Phosphate
6. Megacort
7. Soldesam
8. Dexagro
9. 55203-24-2
10. Decadron Phosphate
11. Dexabene
12. Orgadrone
13. Ak-dex
14. Sodium Dexamethasone Phosphate
15. Dexamethasone 21-(disodium Phosphate)
16. Dexamethasone Phosphate Disodium
17. 2392-39-4 (disodium)
18. Chebi:4462
19. Tlc399
20. Tlc-399
21. Ai9376y64p
22. Nsc-756722
23. Disodium;[2-[(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] Phosphate
24. Spersadox
25. Decdan
26. Solu-decadron
27. Maxidex Ointment
28. Dsstox_cid_27429
29. Dsstox_rid_82342
30. Dsstox_gsid_47429
31. Hexadrol Injectable
32. Disodium [2-[(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] Phosphate
33. Colvasone
34. Dexagel
35. Onadron
36. Baldex
37. Mfcd00079105
38. Dexaject Sp
39. Egp 437
40. Sodium 2-((8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3h-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl Phosphate
41. Cas-2392-39-4
42. Disodium Dexamethasone Phosphate
43. 21-disodium Phosphate Dexamethasone
44. Einecs 219-243-0
45. Dexamethasone-21-phosphate Disodium Salt
46. Dexamethazone Sodium Phosphate
47. Unii-ai9376y64p
48. Ncgc00094644-01
49. Dalalone (tn)
50. Mephamesone
51. Soludecadron
52. Totocortin
53. Solupen N
54. Egp437. Dex-phos
55. Dexamethasone Sodium Phosphate [usp:ban:jan]
56. Schembl7778
57. Decadron Inhalation, Injection, Ophthalmic Solution And Ointment, And Topical Cream
58. 9-fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-(dihydrogen Phosphate) Disodium Salt
59. Chembl2021430
60. Dtxsid3047429
61. Dexamethasone Phosphate Sodium Salt
62. Bcp16805
63. Tox21_113181
64. Tox21_302586
65. S4028
66. Akos015896357
67. Akos015951212
68. Am84812
69. Ccg-269820
70. Ks-1150
71. Nsc 756722
72. Ncgc00256783-01
73. Ac-17992
74. Dexamethasone Sodium Phosphate (jan/usp)
75. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, Disodium Salt, (11.beta.,16.alpha.)-
76. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, Disodium Salt, (11beta,16alpha)-
77. Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-alpha-methyl-, 21-(dihydrogen Phosphate) Disodium Salt
78. Dexamethasone Phosphate (as Sodium)
79. Dexamethasone Sodium Phosphate [jan]
80. B1588
81. Dexamethasone Sodium Phosphate [mart.]
82. Dexamethasone Sodium Phosphate [vandf]
83. En300-52795
84. C08175
85. D00975
86. Dexamethasone Sodium Phosphate [usp-rs]
87. Dexamethasone Sodium Phosphate [who-dd]
88. Dexamethasone Sodium Phosphate [who-ip]
89. A816989
90. A830522
91. Dexamethasone 21-phosphate Disodium Salt, >=98%
92. Dexamethasone Sodium Phosphate [green Book]
93. Dexamethasone Sodium Phosphate [orange Book]
94. Dexamethasone Sodium Phosphate [usp Impurity]
95. Dexamethasoni Natrii Phosphas [who-ip Latin]
96. Dexamethasone 21-phosphate Disodium Salt [mi]
97. Dexamethasone Sodium Phosphate [usp Monograph]
98. Q27106391
99. Neodecadron Component Dexamethasone Sodium Phosphate
100. Dexamethasone Sodium Phosphate Component Of Neodecadron
101. Dexamethasone Sodium Phosphate, British Pharmacopoeia (bp) Reference Standard
102. Dexamethasone Sodium Phosphate, European Pharmacopoeia (ep) Reference Standard
103. Dexamethasone Sodium Phosphate, United States Pharmacopeia (usp) Reference Standard
104. 9-fluoro-11.beta.,17,21-trihydroxy-16.alpha.-methylpregna-1,4-diene-3,20-dione 21-(dihydrogen Phosphate) Disodium Salt
105. Dexamethasone Sodium Phosphate For Peak Identification, European Pharmacopoeia (ep) Reference Standard
106. Dexamethasone Sodium Phosphate, Pharmaceutical Secondary Standard; Certified Reference Material
107. Disodium [2-[(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoranyl-10,13,16-trimethyl-11,17-bis(oxidanyl)-3-oxidanylidene-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxidanylidene-ethyl] Phosphate
108. Disodium 9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregna-1,4-dien-21-yl Phosphate
109. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, Sodium Salt (1:2), (11beta,16alpha)-
| Molecular Weight | 516.4 g/mol |
|---|---|
| Molecular Formula | C22H28FNa2O8P |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 3 |
| Exact Mass | 516.13012157 g/mol |
| Monoisotopic Mass | 516.13012157 g/mol |
| Topological Polar Surface Area | 147 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 962 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
| 1 of 2 | |
|---|---|
| Drug Name | Dexamethasone sodium phosphate |
| Drug Label | Dexamethasone sodium phosphate is a water-soluble inorganic ester of dexamethasone. It occurs as a white or slightly yellow crystalline powder, is odorless or has a slight odor of alcohol, is exceedingly hygroscopic and is freely soluble in water.... |
| Active Ingredient | Dexamethasone sodium phosphate |
| Dosage Form | Injectable; Solution/drops |
| Route | Ophthalmic, otic; Injection |
| Strength | eq 10mg phosphate/ml; eq 0.1% phosphate; eq 4mg phosphate/ml |
| Market Status | Prescription |
| Company | Fresenius Kabi Usa; Hikma Maple; Bausch And Lomb; Alcon Pharms; Luitpold; Agila Speclts |
| 2 of 2 | |
|---|---|
| Drug Name | Dexamethasone sodium phosphate |
| Drug Label | Dexamethasone sodium phosphate is a water-soluble inorganic ester of dexamethasone. It occurs as a white or slightly yellow crystalline powder, is odorless or has a slight odor of alcohol, is exceedingly hygroscopic and is freely soluble in water.... |
| Active Ingredient | Dexamethasone sodium phosphate |
| Dosage Form | Injectable; Solution/drops |
| Route | Ophthalmic, otic; Injection |
| Strength | eq 10mg phosphate/ml; eq 0.1% phosphate; eq 4mg phosphate/ml |
| Market Status | Prescription |
| Company | Fresenius Kabi Usa; Hikma Maple; Bausch And Lomb; Alcon Pharms; Luitpold; Agila Speclts |
Glucocorticoids
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-03-04
Pay. Date : 2022-02-28
DMF Number : 6525
Submission : 1986-08-11
Status : Active
Type : II
Certificate Number : R1-CEP 1998-154 - Rev 06
Issue Date : 2021-07-07
Type : Chemical
Substance Number : 549
Status : Valid
Human Pharmalabs manufacturer of high quality corticosteroid APIs with a state of the art facility in Kalol Gandhinagar.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-01-28
Pay. Date : 2013-01-16
DMF Number : 3963
Submission : 1980-10-10
Status : Active
Type : II
Certificate Number : R2-CEP 1992-014 - Rev 07
Issue Date : 2021-12-16
Type : Chemical
Substance Number : 549
Status : Valid
Registration Number : 222MF10092
Registrant's Address : 15 rue Traversie(')re 75012 Paris France
Initial Date of Registration : 2010-03-17
Latest Date of Registration :
NDC Package Code : 82298-113
Start Marketing Date : 2011-02-07
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Bashu Health Korea Co., Ltd.
Registration Date : 2023-01-06
Registration Number : 20230106-209-J-1432
Manufacturer Name : EUROAPI France
Manufacturer Address : 4 La Paterie, 63480 VERTOLAYE, France
| Available Reg Filing : ASMF |
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
Delivering Quality APIs, Drug Intermediates, and Specialty Chemicals to Over 50 Countries Across the Globe.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Dexamethasone Sodium Phosphate
Brand Name :
Dosage Form : Injection
Dosage Strength : 2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dexamethasone Sodium Phosphate
Dosage : Injection
Dosage Strength : 2ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Dexamethasone Sodium Phosphate
Brand Name :
Dosage Form : Injection
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dexamethasone Sodium Phosphate
Dosage : Injection
Dosage Strength : 4MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Dexamethasone Sodium Phosphate
Brand Name :
Dosage Form : Injection
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dexamethasone Sodium Phosphate
Dosage : Injection
Dosage Strength : 4MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Vietnam
Tobramycin Sulfate; DEXAMETHASONE SODIUM PHOSPHATE
Brand Name : Tobrameson
Dosage Form : Ophthalmic Solution
Dosage Strength : 3MG/ML; 1MG/ML
Packaging : Unit & Multi Dose Ophthalmic
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Vietnam

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : Unit & Multi Dose Ophthalmic
Regulatory Info :
Tobramycin Sulfate; DEXAMETHASONE SODIUM PHOSPHATE
Dosage : Ophthalmic Solution
Dosage Strength : 3MG/ML; 1MG/ML
Brand Name : Tobrameson
Approval Date :
Application Number :
Registration Country : Vietnam

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Dexamethasone Sodium Phosphate
Brand Name :
Dosage Form : Injection
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dexamethasone Sodium Phosphate
Dosage : Injection
Dosage Strength : 4MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Italy
Dexamethasone Sodium Phosphate
Brand Name : DECADRON
Dosage Form : Injection
Dosage Strength : 2MG/ML
Packaging : 10 ml bottle, 30 ml bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 10 ml bottle, 30 ml bottle
Regulatory Info :
Dexamethasone Sodium Phosphate
Dosage : Injection
Dosage Strength : 2MG/ML
Brand Name : DECADRON
Approval Date :
Application Number :
Registration Country : Italy

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : India
Brand Name : Stedex
Dosage Form : INJECTION
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 89280
Regulatory Info : Generic
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info : Generic
Dosage : INJECTION
Dosage Strength : 4MG
Brand Name : Stedex
Approval Date :
Application Number : 89280
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Dexamethasone Sodium Phosphate
Brand Name :
Dosage Form : Injection
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dexamethasone Sodium Phosphate
Dosage : Injection
Dosage Strength : 4MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Turkey
Dexamethasone Sodium Phosphate
Brand Name :
Dosage Form : Parenteral Suspension
Dosage Strength : 40MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dexamethasone Sodium Phosphate
Dosage : Parenteral Suspension
Dosage Strength : 40MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Turkey

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : India
Brand Name : EUDEX
Dosage Form : INJECTION
Dosage Strength : 4MG/ML
Packaging : 2ml amp ; vial
Approval Date :
Application Number : 89280
Regulatory Info : Generic
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 2ml amp ; vial
Regulatory Info : Generic
Dosage : INJECTION
Dosage Strength : 4MG/ML
Brand Name : EUDEX
Approval Date :
Application Number : 89280
Registration Country : India

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Parenteral, Thickeners and Stabilizers
Brand Name : Citric Acid Monohydrate
Application : Parenteral, Thickeners and Stabilizers
Excipient Details : Used as a pH regulator and preservative in many Biological formulations and cell culture media. Also it can be used as a chelating agent.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Citric Acid Excipient
Application : Parenteral
Excipient Details : Used as an osmolarity agent in culture media, tonicity adjuster in ophthalmics and parenterals solutions.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Sodium Chloride Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Parenteral, Thickeners and Stabilizers
Application : Parenteral, Thickeners and Stabilizers
Excipient Details : Used as a chelating agent in cell culture media, downstream and as a chelator stabilizer in Biopharmaceutical formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Disodium Edetate Excipient
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Tablet
Grade : Parenteral, Oral, Topical
Category : Parenteral, Solubilizers, Topical
Brand Name : Trisodium Citrate
Application : Parenteral
Excipient Details : Used as a buffering agent in purification process during downstream and in the final formulation.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Trisodium Citrate Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Parenteral, Surfactant & Foaming Agents
Application : Parenteral, Surfactant & Foaming Agents
Excipient Details : Used as surfactant agent in cell culture media, in protein purification and in injectable formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Polysorbate 80
Dosage Form : Nasal Solution, Ophthalmic Solution
Grade : Ophthalmic and Nasal
Category : Parenteral
Brand Name : Benzalkonium Chloride
Application : Parenteral
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Benzalkonium Chloride Excipient
Excipients Web Link
Dosage Form : Capsule, Cream / Lotion / Ointment, Suspension, Tablet
Grade : Oral, Topical & Parenteral
Category : Solubilizers, Surfactant & Foaming Agents
Application : Solubilizers, Surfactant & Foaming Agents
Excipient Details : Polysorbate 80 acts as solubilizer, emulsifier and wetting agent.
Excipients Web Link
Dosage Form : Cream / Lotion / Ointment, Injectable / Parenteral
Grade : Parenteral and Topical
Category : Parenteral, Topical
Application : Parenteral, Topical
Excipients Web Link
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Parenteral, Surfactant & Foaming Agents
Application : Parenteral, Surfactant & Foaming Agents
Excipient Details : Used as surfactant agent in cell culture media, in protein purification and in injectable formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Polysorbate 80
Dosage Form : Capsule, Cream / Lotion / Ointment, Suspension, Tablet
Grade : Oral, Topical & Parenteral
Category : Solubilizers, Surfactant & Foaming Agents
Application : Solubilizers, Surfactant & Foaming Agents
Excipient Details : Polysorbate 80 acts as solubilizer, emulsifier and wetting agent.
Excipients Web Link
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Paste, Shampoo, Solution, Syrup, Tablet
Grade : Topical, Oral
Category : Film Formers & Plasticizers, Solubilizers, Surfactant & Foaming Agents, Topical
Brand Name : MONTANOX 80 PHA PREMIUM
Application : Film Formers & Plasticizers, Solubilizers, Surfactant & Foaming Agents, Topical
Excipient Details : Non-Ionic Hydrophilic Surfactant, Emulsifier, Solubilizer
Pharmacopoeia Ref : Ph.Eur, USP-NF
Technical Specs : HLB: 15, EO: 20; EXCiPACT
Ingredient(s) : Polysorbate 80
Dosage Form : Capsule, Cream / Lotion / Ointment, Tablet
Grade : Oral, Topical
Category : Emulsifying Agents, Solubilizers, Surfactant & Foaming Agents, Topical
Brand Name : MONTANOX 80 PHA PREMIUM
Application : Emulsifying Agents, Solubilizers, Surfactant & Foaming Agents, Topical
Pharmacopoeia Ref : USP-NF, EP, JP
Technical Specs : Non-Ionic Hydrophilic surfactant, Emulsifier (o/w emulsion), Solu...
Ingredient(s) : Polysorbate 80
Dosage Form : Capsule, Tablet, Dry Syrup
Grade : Oral
Category : Co-Processed Excipients, Direct Compression, Solubilizers
Application : Co-Processed Excipients, Direct Compression, Solubilizers
Excipient Details : Solubilizer
Pharmacopoeia Ref : Not Available
Technical Specs : Solubilizer in powder form; EXCiPACT
Ingredient(s) : Polysorbate 80
Grade : Oral
Category : API Stability Enhancers, Direct Compression, Solubilizers
Application : API Stability Enhancers, Direct Compression, Solubilizers
Excipient Details : Polysorbate 80 in dry powder form, a solubilizing agent acts as a surfactant and increases the solubility of various oral dosage forms.
Pharmacopoeia Ref : USP-NF, EP, JP & having US DMF
Technical Specs : Solubilizer in powder form, used in directly compressible dosage ...
Ingredient(s) : Magnesium aluminium silicate Excipient
https://www.pharmacompass.com/radio-compass-blog/dmf-filings-rise-4-5-in-q3-2025-china-holds-lead-india-records-20-growth-in-submissions

10 Nov 2025
// BUSINESS WIRE
https://www.businesswire.com/news/home/20251021956399/en/Quince-Therapeutics-Announces-Positive-iDSMB-Review-for-eDSP-in-Pivotal-Phase-3-NEAT-Clinical-Trial-in-Ataxia-Telangiectasia

25 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250925856162/en/Quince-Therapeutics-Announces-CPT-Pharmacometrics-Systems-Pharmacology-Publication-of-eDSP-Population-Pharmacokinetic-Modeling-Study

26 Jun 2024
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-26-2024-3489.pdf

03 Jun 2024
// BUSINESSWIRE

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211451
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214890
Global Sales Information
Company : App/Fresenius K
Dexamethasone Sodium Phosp/PF
Drug Cost (USD) : 26,406
Year : 2023
Prescribers : 1128
Prescriptions : 2236

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Auromedics-Eugi
Dexamethasone Sodium Phosp/PF
Drug Cost (USD) : 11,417
Year : 2023
Prescribers : 282
Prescriptions : 502

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Fresenius Kabi
Dexamethasone Sodium Phosp/PF
Drug Cost (USD) : 122
Year : 2023
Prescribers :
Prescriptions : 13

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Fresenius-Premi
Dexamethasone Sodium Phosp/PF
Drug Cost (USD) : 187
Year : 2023
Prescribers : 18
Prescriptions : 33

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Somerset Therap
Dexamethasone Sodium Phosp/PF
Drug Cost (USD) : 15,702
Year : 2023
Prescribers : 285
Prescriptions : 605

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : App-Premierpro
Dexamethasone Sodium Phosphate
Drug Cost (USD) : 4,456
Year : 2023
Prescribers : 505
Prescriptions : 730

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : App/Fresenius K
Dexamethasone Sodium Phosphate
Drug Cost (USD) : 26,445
Year : 2023
Prescribers : 856
Prescriptions : 1258

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Auromedics-Eugi
Dexamethasone Sodium Phosphate
Drug Cost (USD) : 14,856
Year : 2023
Prescribers : 1000
Prescriptions : 1143

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Bausch & Lomb I
Dexamethasone Sodium Phosphate
Drug Cost (USD) : 3,459,505
Year : 2023
Prescribers : 41917
Prescriptions : 67719

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Fresenius Kabi
Dexamethasone Sodium Phosphate
Drug Cost (USD) : 56,360
Year : 2023
Prescribers : 3565
Prescriptions : 7076

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Reply
07 Jul 2023
Reply
09 Mar 2023
Reply
23 Apr 2022
Reply
29 Nov 2021
Reply
24 Aug 2021
Reply
12 Jul 2021
Reply
14 Jun 2021
Reply
22 Mar 2021
Reply
13 Sep 2018
Reply
12 Oct 2017
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
CAS Number : 125-02-0
Quantity Per Vial : 100 mg
Sale Unit : 1
Order Code : P2810000
Batch No : 4
Price (€) : 79
Storage : +5°C ± 3°C

Dexamethasone sodium phosphate for peak identification
CAS Number : 2392-39-4
Quantity Per Vial : 10 mg
Sale Unit : 1
Order Code : Y0001477
Batch No : 1
Price (€) : 79
Storage : +5°C ± 3°C

Dexamethasone sodium phosphate
CAS Number : 2392-39-4
Quantity Per Vial : 130 mg
Sale Unit : 1
Order Code : D0720000
Batch No : 7
Price (€) : 79
Storage : +5°C ± 3°C

Betamethasone sodium phosphate
CAS Number : 151-73-5
Quantity Per Vial : 100 mg
Sale Unit : 1
Order Code : B1045000
Batch No : 4
Price (€) : 79
Storage : +5°C ± 3°C

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dexamethasone Phosphate (500 mg)
CAS Number : 312-93-6
Quantity Per Vial : 500
Sale Unit : mg
Price : $245.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1177000 / R107K0

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
86
PharmaCompass offers a list of Dexamethasone Sodium Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dexamethasone Sodium Phosphate manufacturer or Dexamethasone Sodium Phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dexamethasone Sodium Phosphate manufacturer or Dexamethasone Sodium Phosphate supplier.
PharmaCompass also assists you with knowing the Dexamethasone Sodium Phosphate API Price utilized in the formulation of products. Dexamethasone Sodium Phosphate API Price is not always fixed or binding as the Dexamethasone Sodium Phosphate Price is obtained through a variety of data sources. The Dexamethasone Sodium Phosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dexamethasone Metasulfobenzoate Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dexamethasone Metasulfobenzoate Sodium, including repackagers and relabelers. The FDA regulates Dexamethasone Metasulfobenzoate Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dexamethasone Metasulfobenzoate Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dexamethasone Metasulfobenzoate Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dexamethasone Metasulfobenzoate Sodium supplier is an individual or a company that provides Dexamethasone Metasulfobenzoate Sodium active pharmaceutical ingredient (API) or Dexamethasone Metasulfobenzoate Sodium finished formulations upon request. The Dexamethasone Metasulfobenzoate Sodium suppliers may include Dexamethasone Metasulfobenzoate Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Dexamethasone Metasulfobenzoate Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dexamethasone Metasulfobenzoate Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Dexamethasone Metasulfobenzoate Sodium active pharmaceutical ingredient (API) in detail. Different forms of Dexamethasone Metasulfobenzoate Sodium DMFs exist exist since differing nations have different regulations, such as Dexamethasone Metasulfobenzoate Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dexamethasone Metasulfobenzoate Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Dexamethasone Metasulfobenzoate Sodium USDMF includes data on Dexamethasone Metasulfobenzoate Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dexamethasone Metasulfobenzoate Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dexamethasone Metasulfobenzoate Sodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Dexamethasone Metasulfobenzoate Sodium Drug Master File in Japan (Dexamethasone Metasulfobenzoate Sodium JDMF) empowers Dexamethasone Metasulfobenzoate Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Dexamethasone Metasulfobenzoate Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Dexamethasone Metasulfobenzoate Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Dexamethasone Metasulfobenzoate Sodium suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Dexamethasone Metasulfobenzoate Sodium Drug Master File in Korea (Dexamethasone Metasulfobenzoate Sodium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Dexamethasone Metasulfobenzoate Sodium. The MFDS reviews the Dexamethasone Metasulfobenzoate Sodium KDMF as part of the drug registration process and uses the information provided in the Dexamethasone Metasulfobenzoate Sodium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Dexamethasone Metasulfobenzoate Sodium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Dexamethasone Metasulfobenzoate Sodium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Dexamethasone Metasulfobenzoate Sodium suppliers with KDMF on PharmaCompass.
A Dexamethasone Metasulfobenzoate Sodium CEP of the European Pharmacopoeia monograph is often referred to as a Dexamethasone Metasulfobenzoate Sodium Certificate of Suitability (COS). The purpose of a Dexamethasone Metasulfobenzoate Sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dexamethasone Metasulfobenzoate Sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dexamethasone Metasulfobenzoate Sodium to their clients by showing that a Dexamethasone Metasulfobenzoate Sodium CEP has been issued for it. The manufacturer submits a Dexamethasone Metasulfobenzoate Sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dexamethasone Metasulfobenzoate Sodium CEP holder for the record. Additionally, the data presented in the Dexamethasone Metasulfobenzoate Sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dexamethasone Metasulfobenzoate Sodium DMF.
A Dexamethasone Metasulfobenzoate Sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dexamethasone Metasulfobenzoate Sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Dexamethasone Metasulfobenzoate Sodium suppliers with CEP (COS) on PharmaCompass.
A Dexamethasone Metasulfobenzoate Sodium written confirmation (Dexamethasone Metasulfobenzoate Sodium WC) is an official document issued by a regulatory agency to a Dexamethasone Metasulfobenzoate Sodium manufacturer, verifying that the manufacturing facility of a Dexamethasone Metasulfobenzoate Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dexamethasone Metasulfobenzoate Sodium APIs or Dexamethasone Metasulfobenzoate Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Dexamethasone Metasulfobenzoate Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Dexamethasone Metasulfobenzoate Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dexamethasone Metasulfobenzoate Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dexamethasone Metasulfobenzoate Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dexamethasone Metasulfobenzoate Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dexamethasone Metasulfobenzoate Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dexamethasone Metasulfobenzoate Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dexamethasone Metasulfobenzoate Sodium suppliers with NDC on PharmaCompass.
Dexamethasone Metasulfobenzoate Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dexamethasone Metasulfobenzoate Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dexamethasone Metasulfobenzoate Sodium GMP manufacturer or Dexamethasone Metasulfobenzoate Sodium GMP API supplier for your needs.
A Dexamethasone Metasulfobenzoate Sodium CoA (Certificate of Analysis) is a formal document that attests to Dexamethasone Metasulfobenzoate Sodium's compliance with Dexamethasone Metasulfobenzoate Sodium specifications and serves as a tool for batch-level quality control.
Dexamethasone Metasulfobenzoate Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Dexamethasone Metasulfobenzoate Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dexamethasone Metasulfobenzoate Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Dexamethasone Metasulfobenzoate Sodium EP), Dexamethasone Metasulfobenzoate Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dexamethasone Metasulfobenzoate Sodium USP).